MarketInOut Stock Screener Log In | Sign Up

Nurix Therapeutics Inc

IEX • Healthcare • Biotechnology • Quote as of 10/30/2026
Nurix Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization2,927.9 mln
Float104 mln
Earnings Date02/17/2027

EPS

2.43
Solid

P / E

11.02
Fair value

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

5.31
Highly suspicious

1-Year Forecast

34.50
Strong upside

Relative Strength

90 / 100
Top performer

Business Description

Nurix Therapeutics is a clinical-stage drug company based in Brisbane, California, focused on developing oral medicines that treat cancer, autoimmune disorders, and other serious diseases by targeting and breaking down specific disease-causing proteins. The company has several drugs in clinical trials, including treatments for hard-to-treat blood cancers and inflammatory conditions such as rheumatoid arthritis. Nurix works alongside major pharmaceutical companies, including Gilead Sciences, Sanofi, and Pfizer, to advance and bring these medicines to market.

Key Fundamentals

EPS2.43
P/E11.02
ROE53.37
RPS6.56
ROIC210
ROA41.05
EBITDA, mln324
EV / EBITDA6.52
EV / EBIT6.86
Revenue, mln702
EV / Revenue3.01

Quote Details

Last 26.80
Change -0.32 (-1.18%)
Open 26.90
Volume 1,805,427
Turnover 48,385,444
Average Volume 1,819,155

Financial Ratios

Pre-Tax Profit Margin44
Leverage Ratio1.23
Current Ratio8.44
Price / Book3.01
Price / Tangible Book3.01
Price / Cash Flow7.88
Price / Free Cash Flow8.99
Debt / Equity0.07
Price / Sales4.39
PEG Ratio2.10

Financial Strength

Altman Z-Score9.39
Piotroski F-Score 8 / 9
Beneish M-Score5.31
Price to Intrinsic Value16.28
Price to Graham Number1.24
1-Year Target Price34.50
Short Ratio10.30
Short % of Float19.06

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.76% 89 / 100   
1 Month 14.82% 93 / 100   
2 Months 14.38% 89 / 100   
6 Months 59.43% 97 / 100   
1 Year 129% 97 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog